Scaling lentiviral vector manufacturing without tradeoffs: achieving higher purity and lower COGS through smarter bioprocessing

The scale-X bioreactor provides a biology-aligned alternative for scalable and cost effective production of LV, enabling decreased costs and patient accessibility.

In our interactive summary and video, Thomas Robert (Senior Innovation & Product Manager, Univercells Technologies) shows you how you can achieve:

✓

2–3x maintained or increased functional titers

✓

3–20x lower contaminants in harvest

✓

up to 2–3x increased DSP recovery

✓

25–65% COGs savings per dose

▶

Click image above to see a taster video

Want to learn more?

View the interactive summary and video for free by clicking the link below.

✕

Please enter your email to access content Read now